Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Cherie L. Butts"'
Publikováno v:
Frontiers in Immunology, Vol 4 (2014)
Neutralizing antibody formation against transgene products can represent a major complication following gene therapy with treatment of genetic diseases, such as hemophilia A. Although successful approaches have been developed to prevent the formation
Externí odkaz:
https://doaj.org/article/439271d693fb4990a67aa9ed059dc2f6
Autor:
Lasair O’Callaghan, Saira Z Sheikh, Cherie L. Butts, Janine Gaiha-Rohrbach, Lina Sladkeviciute, Maria L. Naylor
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss Suppl 2 (2021)
Background Lupus disproportionately affects Black/African American (AA) and Latino/a patients, yet these underrepresented racial/ethnic minority populations often face challenges with accessing quality care.1,2 We aimed to explore patients’ and phy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6e3b31fae4f1312eebb1745fe643d23
https://doaj.org/article/d726b45a9cbc4235b29a7cefa321754c
https://doaj.org/article/d726b45a9cbc4235b29a7cefa321754c
Autor:
Himanshu Naik, Kun Chen, Maria L. Naylor, Achint Kumar, Li Zhu, Cherie L. Butts, Nancy Ramia, Yuan Zhao, Sangeeta Sahu
Publikováno v:
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Background: Peginterferon beta-1a administered every 2 weeks via subcutaneous (SC) injection is approved to treat adult patients with relapsing-remitting multiple sclerosis (RRMS) and relapsing forms of multiple sclerosis (RMS). However, associated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c1ce1a6c526357672fe142fbe12212
https://pubmed.ncbi.nlm.nih.gov/33628334
https://pubmed.ncbi.nlm.nih.gov/33628334
Publikováno v:
The Journal of Immunology. 204:160.13-160.13
Background Developing effective therapies for patients can be difficult as many fail due to safety concerns. Changes in route of administration (ROA) for approved therapies offers options to patients while mitigating known side effects. Peginterferon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b2dac2dc721bdd53d4b3c688c342c7e
https://doi.org/10.4049/jimmunol.204.supp.160.13
https://doi.org/10.4049/jimmunol.204.supp.160.13
Autor:
Cherie L. Butts
Publikováno v:
Nature Immunology. 21:235-235
As scientists, we develop technical expertise and design experiments to support (or refute) our hypotheses. With experience, we appreciate that science can be conducted in a variety of ways — each with different key questions. All are critical for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c9e20ee542dff93b1299bc118c7a30
https://doi.org/10.1038/s41590-020-0608-6
https://doi.org/10.1038/s41590-020-0608-6
Autor:
Cherie L. Butts, JoAnn V. Pinkerton, Michael T. McDermott, Nanette Santoro, Glenn D. Braunstein, Kathryn A. Martin
Publikováno v:
The Journal of clinical endocrinology and metabolism. 101(4)
Context: Custom-compounded bioidentical hormone therapy (HT) has become widely used in current endocrine practice, which has led to unnecessary risks with treatment. Objective: This scientific statement reviews the pharmacology and physiology of popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d70608b2cd971f77575865ae823e15e4
https://pubmed.ncbi.nlm.nih.gov/27032319
https://pubmed.ncbi.nlm.nih.gov/27032319
Tissue expression of steroid hormone receptors is associated with differential immune responsiveness
Autor:
Elena Belyavskaya, Esther M. Sternberg, Caroline E. Salter, Cherie L. Butts, Jean K. Lim, Yava L. Jones
Publikováno v:
Brain, Behavior, and Immunity. 25:1000-1007
Glucocorticoids and other steroid hormones have been used as treatments against a number of diseases, especially inflammatory conditions in which the immune system is overactive. These treatments have varying degrees of responsiveness among individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45af628347542b315bae55a107316a9f
https://doi.org/10.1016/j.bbi.2010.11.003
https://doi.org/10.1016/j.bbi.2010.11.003
Publikováno v:
Journal of Leukocyte Biology. 84:924-931
A bidirectional communication exists between the CNS and the immune system. The autonomic nervous system, through neurotransmitters and neuropeptides, works in parallel with the hypothalamic-pituitary-adrenal axis through the actions of glucocorticoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64a2bfb4fe778a19cb5ed531a77263ec
https://doi.org/10.1189/jlb.0208104
https://doi.org/10.1189/jlb.0208104
Publikováno v:
Nature Reviews Immunology. 16:715-716
Immunologists appreciate the need for creative approaches to tackle complex scientific questions, which can involve not only the use of novel technologies but also the experience of scientists from diverse backgrounds. Here, we highlight measures to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5e4483872cbce4d5eaf0125a60272b
https://doi.org/10.1038/nri.2016.122
https://doi.org/10.1038/nri.2016.122
Autor:
Cherie L. Butts, Aymen Al-Shamkhani, Ann L. White, Ruth R. French, Mark S. Cragg, Emily L Williams, Stephen A. Beers, Peter Johnson, Martin J. Glennie, Elizabeth A. Potter, J. Sjef Verbeek, Lang Dou, Steven G. Booth, C. Ian Mockridge, Kane Moss, Vikki L Field, H.T. Claude Chan
Publikováno v:
Journal of Immunology, 193(4), 1828-1835
Immunomodulatory mAbs, led by the anti-CTLA4 mAb ipilimumab, are an exciting new class of drugs capable of promoting anticancer immunity and providing durable control of some tumors. Close analysis of a number of agents has revealed a critical yet va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e82a207940b88f0c8c8e92783ded68
https://hdl.handle.net/1887/104737
https://hdl.handle.net/1887/104737
